Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gaucher disease is an inherited disorder that affects many of the body's organs and tissues. The signs and symptoms of this condition vary widely among affected individuals. The lack of drugs in last stage of development is anticipated to limit the expansion of the Gaucher disease market, although the rise in number of patient globally tend to favor the growth of Gaucher disease treatment in the market over the forecast period.
Increased focus on formation of research consortiums on rare diseases is leading to rising disease awareness levels and increased reporting of such diseases too. Furthermore, rising affordability for access to essential healthcare services is contributing largely to disease testing and identification at early stages.United States dominates the global market for Gaucher disease treatment market due to high diagnose rate and large number of facilities for enzyme replacement therapy. However, growth in Middle East and African region is expected to take exponential growth in terms of CAGR over the forecast period.
The report details the trend, potential and market size of Gaucher Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gaucher Disease Treatmentmarket, defines the market attractiveness level of Gaucher Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gaucher Disease Treatment industry, describes the types of Gaucher Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gaucher Disease Treatment market and the development prospects and opportunities of Gaucher Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gaucher Disease Treatment market in Chapter 13.
By Player:
ISU ABXIS
Actelion Pharma
Pfizer (Protalix)
Shire
Sanofi
By Type:
Enzyme replacement therapy
Substrate reduction therapy
By End-User:
Non-neuronopathic Gaucher disease
Neuronopathic Gaucher disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gaucher Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gaucher Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gaucher Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gaucher Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gaucher Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Gaucher Disease Treatment Consumption (2017-2022)
-
7.2 United States Gaucher Disease Treatment Consumption (2017-2022)
-
7.3 Europe Gaucher Disease Treatment Consumption (2017-2022)
-
7.4 China Gaucher Disease Treatment Consumption (2017-2022)
-
7.5 Japan Gaucher Disease Treatment Consumption (2017-2022)
-
7.6 India Gaucher Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Gaucher Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Gaucher Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Gaucher Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Gaucher Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Gaucher Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Gaucher Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Gaucher Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Gaucher Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Gaucher Disease Treatment Consumption Forecast (2022-2028)
9 Global Gaucher Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Gaucher Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Enzyme replacement therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Substrate reduction therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Gaucher Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Non-neuronopathic Gaucher disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neuronopathic Gaucher disease Consumption and Growth Rate (2017-2022)
10 Global Gaucher Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Gaucher Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Enzyme replacement therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Substrate reduction therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gaucher Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Non-neuronopathic Gaucher disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neuronopathic Gaucher disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Gaucher Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gaucher Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gaucher Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gaucher Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gaucher Disease Treatment Market Competitive Analysis
-
14.1 ISU ABXIS
-
14.1.1 ISU ABXIS Company Details
-
14.1.2 ISU ABXIS Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ISU ABXIS Gaucher Disease Treatment Product and Service
-
14.2 Actelion Pharma
-
14.2.1 Actelion Pharma Company Details
-
14.2.2 Actelion Pharma Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Actelion Pharma Gaucher Disease Treatment Product and Service
-
14.3 Pfizer (Protalix)
-
14.3.1 Pfizer (Protalix) Company Details
-
14.3.2 Pfizer (Protalix) Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer (Protalix) Gaucher Disease Treatment Product and Service
-
14.4 Shire
-
14.4.1 Shire Company Details
-
14.4.2 Shire Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Shire Gaucher Disease Treatment Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Gaucher Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gaucher Disease Treatment
-
Figure Gaucher Disease Treatment Picture
-
Table Global Gaucher Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gaucher Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gaucher Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gaucher Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Gaucher Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Gaucher Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Gaucher Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Gaucher Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Gaucher Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gaucher Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Gaucher Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Gaucher Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gaucher Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gaucher Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gaucher Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gaucher Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gaucher Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme replacement therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Substrate reduction therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Non-neuronopathic Gaucher disease Consumption and Growth Rate (2017-2022)
-
Figure Global Neuronopathic Gaucher disease Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme replacement therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Substrate reduction therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-neuronopathic Gaucher disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuronopathic Gaucher disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gaucher Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gaucher Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table ISU ABXIS (Foundation Year, Company Profile and etc.)
-
Table ISU ABXIS Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table ISU ABXIS Gaucher Disease Treatment Product and Service
-
Table Actelion Pharma (Foundation Year, Company Profile and etc.)
-
Table Actelion Pharma Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actelion Pharma Gaucher Disease Treatment Product and Service
-
Table Pfizer (Protalix) (Foundation Year, Company Profile and etc.)
-
Table Pfizer (Protalix) Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer (Protalix) Gaucher Disease Treatment Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Gaucher Disease Treatment Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Gaucher Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Gaucher Disease Treatment Product and Service
-
